5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.73▼ | 3.73▼ | 3.74▼ | 3.94▼ | 4.15▼ |
MA10 | 3.72▼ | 3.75▼ | 3.78▼ | 4.14▼ | 4.42▼ |
MA20 | 3.72▼ | 3.78▼ | 3.83▼ | 4.18▼ | 4.87▼ |
MA50 | 3.75▼ | 3.87▼ | 4.08▼ | 4.50▼ | 5.69▼ |
MA100 | 3.78▼ | 4.10▼ | 4.15▼ | 4.97▼ | 4.95▼ |
MA200 | 3.83▼ | 4.16▼ | 4.35▼ | 5.75▼ | 4.55▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | -0.001▼ | 0.002▲ | -0.039▼ | -0.089▼ |
RSI | 32.505▼ | 23.308▼ | 18.649▼ | 29.447▼ | 30.086▼ |
STOCH | 70.000 | 8.532▼ | 14.931▼ | 26.306 | 11.714▼ |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -98.718▼ | -99.425▼ |
CCI | -141.968▼ | -121.185▼ | -133.737▼ | -158.586▼ | -151.989▼ |
Monday, June 09, 2025 05:00 PM
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic ...
|
Monday, June 09, 2025 01:14 PM
MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative inhaled therapeutic products and devices to address serious unmet medical needs for those living ...
|
Friday, May 09, 2025 07:40 AM
In this article, we are going to take a look at where MannKind Corporation (NASDAQ:MNKD) stands against other best cancer stocks to invest in for long-term gain. After cardiovascular disease ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 3.80 | 3.81 | 3.70 | 3.71 | 1,781,039 |
12/06/25 | 3.86 | 3.88 | 3.80 | 3.83 | 1,862,583 |
11/06/25 | 3.97 | 3.985 | 3.87 | 3.88 | 3,608,725 |
10/06/25 | 4.10 | 4.13 | 3.90 | 3.91 | 7,110,139 |
09/06/25 | 4.44 | 4.48 | 4.36 | 4.37 | 1,598,728 |
06/06/25 | 4.30 | 4.39 | 4.30 | 4.38 | 1,567,208 |
05/06/25 | 4.35 | 4.35 | 4.27 | 4.30 | 1,126,427 |
04/06/25 | 4.43 | 4.48 | 4.32 | 4.35 | 2,241,359 |
03/06/25 | 4.29 | 4.465 | 4.25 | 4.42 | 2,568,607 |
02/06/25 | 4.13 | 4.35 | 4.13 | 4.29 | 2,005,205 |
|
|
||||
|
|
||||
|
|